2018-2019 AdooQ 最新目录册 点击此处下载

Apoptosis | 凋亡

The process of programmed cell death (PCD), or apoptosis, is generally characterized by distinct morphological characteristics and energy-dependent biochemical mechanisms. Apoptosis is considered a vital component of various processes including normal cell turnover, proper development and functioning of the immune system, hormone-dependent atrophy, embryonic development and chemical-induced cell death. Inappropriate apoptosis (either too little or too much) is a factor in many human conditions including neurodegenerative diseases, ischemic damage, autoimmune disorders and many types of cancer. 

The mechanisms of apoptosis are highly complex and sophisticated, involving an energy-dependent cascade of molecular events. To date, research indicates that there are two main apoptotic pathways: the extrinsic or death receptor pathway and the intrinsic or mitochondrial pathway. However, there is now evidence that the two pathways are linked and that molecules in one pathway can influence the other.

 There are many pathological conditions that feature excessive apoptosis and thus may benefit from artificially inhibiting apoptosis. A short list of potential methods of anti-apoptotic therapy includes stimulation of the IAP (inhibitors of apoptosis proteins) family of proteins, caspase inhibition, PARP (poly polymerase) inhibition, stimulation of the PKB/Akt (protein kinase B) pathway, and inhibition of Bcl-2 proteins. So far, members of the IAP family have been investigated as therapeutic targets for the treatment of stroke, spinal cord injuries, multiple sclerosis as well as cancer. The synthetic nonspecific caspase inhibitor z-VAD-fmk was shown to reduce the severity of myocardial reperfusion injury in rat and mouse models of myocardial infarction. Specific inhibitors of caspase activity may also prove beneficial.

产品 1 到 50 共 145个

  1. 1
  2. 2
  3. 3

Catalog No. Product Name Application Product Information
A12907 SALE


Bax activator
BAM 7 binds the BAX trigger site with an EC50 ~ 3.3 μM as measured in a competitive FP assay using FITC-BIM SAHB and BAX.

AT101 acetic acid

pan Bcl-2 抑制剂
AT101, the R-(-) enantiomer of Gossypol acetic acid, binds with Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.32 μM, 0.48 μM and 0.18 μM; does not inhibit BIR3 domain and BID

Bcl-2 Inhibitor

Bcl-2 抑制剂
Bcl-2 Inhibitor contains a mixture of two tautomers. A potent, cell-permeable, Bcl-2 inhibitor competes with Bak BH3 peptide for binding to Bcl-2 and Bcl-XL in vitro (IC50 =10 uM and 7 uM, respectively).

Acetate gossypol

Bcl-2 抑制剂
Acetate gossypol, a polyphenolic compound isolated from cottonseeds, inhibits Bcl-2 by acting as a BH3 mimetic.
A10255 SALE


Bcl-2 抑制剂
ABT-737 is a pan-Bcl-2 inhibitor. IC50 values ranged from 192 nM (the pre-B cell line Hal-01) to <10 μM (Nalm-6, K562 and HL-60).
A10022 SALE

ABT-263 (Navitoclax)

Bcl-2 抑制剂
ABT-263 (Navitoclax) is a potent orally bioavailable SMI that is structurally related to ABT-737. ABT-263 disrupts Bcl-2 - Bcl-XL interactions with pro-apoptotic proteins .
A10665 SALE

Obatoclax mesylate (GX15-070)

Bcl-2 抑制剂
Bcl-2 homology domain-3 (BH3) mimetic,antagonize all antiapoptotic Bcl-2 family proteins (average IC50, 3 umol/L), including Mcl-1 (IC50, 2.9 umol/L) and Bfl-1 (IC50, 5 umol/L).


Bcl-2 抑制剂
TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer mediated through a novel pathway involving inactivation of Notch-1 and Jagged-1.
A11448 SALE


Bcl-2 抑制剂
HA14-1 interacts with Bcl-2 and inhibits the antiapoptotic effect of Bcl-2.
A11988 SALE

Gambogic acid

Bcl-2 抑制剂
Gambogic acid is a natural product isolated from the Garcinia hanburyi tree. Gambogic Acid activates caspases with EC50 of 0.78-1.64 μM and competitively inhibits Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1 with IC50 of 1.47, 1.21, 2.02, 0.66, 1.06 and 0.79 μM, respectively.


Bcl-2/Bcl-xL 抑制剂
BM-1074 is a potent and efficacious Bcl-2/Bcl-xL inhibitor with Ki of <1 nM.


Bcl-2 抑制剂
Sabutoclax(BI-97C1) is a pan-Bcl-2 inhibitor, including Bcl-xL, Bcl-2, Mcl-1 and Bfl-1 with IC50 of 0.31 μM, 0.32 μM, 0.20 μM and 0.62 μM, respectively.
A12500 SALE

ABT-199 (Venetoclax)

Bcl-2 抑制剂
ABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.
A14222 SALE


Mcl-1 抑制剂
UMI-77 is a selective Mcl-1 inhibitor with Ki of 490 nM, showing selectivity over other members of Bcl-2 family.

Bax channel blocker

Bax channel blocker
Bax channel blocker is a potent inhibitor of Bax-mediated mitochondrial cytochrome C release (IC50 = 0.52 μM).

Bax inhibitor peptide P5

Bax 抑制剂
Bax inhibitor peptide P5, cell-permeable synthetic peptide inhibitor of Bax translocation to mitochondria; designed from Ku70, a protein that is suggested to suppress the mitochondrial translocation of Bax. Inhibits Bax-mediated apoptosis in vitro.
A15337 SALE

Bax inhibitor peptide V5

Bax 抑制剂
Bax inhibitor peptide V5, cell-permeable synthetic peptide inhibitor of Bax translocation to mitochondria; designed from Ku70, a protein that is suggested to suppress the mitochondrial translocation of Bax. Inhibits Bax-mediated apoptosis in vitro.

Bax inhibitor peptide, negative control

Bax 抑制剂
Bax inhibitor peptide, negative control, negative control peptide for the Bax inhibitor peptides V5 and P5 , which inhibit Bax translocation to mitochondria and Bax-mediated apoptosis in vitro.

Muristerone A

EcR 激动剂
Muristerone A is a phytoecdysteroid analog of ecdysone which induces genes in mammalian cells and causes apoptosis in cells transfected with wild-type Bax.


Bcl-2 抑制剂
AT101, the R-(-) enantiomer of Gossypol acetic acid, binds with Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.32μM, 0.48μM and 0.18μM.


MCL-1 抑制剂
A-1210477 is a potent and selective MCL-1 inhibitor. A-1210477 induces the hallmarks of intrinsic apoptosis and demonstrates single agent killing of multiple myeloma and non-small cell lung cancer cell lines.


Bcl-2 拮抗剂
BDA-366 selectively inhibits BCL2, converting it to a cell death inducer.
A16061 SALE


Bcl-XL 拮抗剂
BH3I-1 is a cell permeable BH3 mimetic that binds to Bcl-xL


BCL-XL 抑制剂
A-1155463 is a highly potent and selective BCL-XL inhibitor, A-1155463 shows picomolar binding affinity to BCL-XL (Ki ??0.01 nM), and >1000-fold weaker binding to BCL-2 (Ki = 80 nM) and related proteins BCL-W (Ki = 19 nM) and MCL-1 (Ki > 440 nM)


BCL-XL 抑制剂
A-1331852 is a potent and selective BCL-XL inhibitor. BCL-XL is the major antiapoptotic survival protein and may be a novel therapeutic target in CML.


BCL6 抑制剂
CID5721353 is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor).

WEHI-539 hydrochloride

Bcl-xL 抑制剂
WEHI-539 hydrochloride is a small-molecule inhibitor of BCL-xL with IC50 value of 1.1 nM [1].

Apogossypolone (ApoG2)

Bcl-2 抑制剂
Apogossypolone is a nonpeptidic small-molecule inhibitor of Bcl-2 with


Mcl-1 抑制剂
MIM1 is a selective small molecule inhibitor of Mcl-1(IC50= 4.8 μM) that overcomes Mcl-1-dependent leukemia cell survival.


Bcl-2 family 抑制剂
(+)-Apogossypol is a potent inhibitor of Bcl-2 family proteins; competing with the BH3 peptide-binding sites on Bcl-2, Bcl-XL, Mcl-1, Bcl-W, and Bcl-B, but not Bfl-1, with IC50s of 0.5 to 2 μM.

(S)-Gossypol acetic acid

Bcl-2 抑制剂
(S)-Gossypol acetic acid is a inhibitor of Bcl-2, potently induce cell death in Jurkat cells overexpressing Bcl-2 (IC50, 18.1μM) or Bcl-xL (IC50, 22.9μM).


Mcl-1 抑制剂
Pyridoclax is a potent Mcl-1 inhibitor with Kd value of 25 nM.
A12373 SALE


Pan Caspase 抑制剂
Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor. Inhibits caspase processing and apoptosis induction in tumor cells in vitro (IC50 = 0.0015 - 5.8 mM). Active in vivo.

Nivocasan (GS-9450)

Caspase 抑制剂
Nivocasan is a novel caspase-inhibitor has demonstrated hepatoprotective activity in fibrosis/apoptosis animal models.
A13503 SALE


Caspase-3 抑制剂
Z-DEVD-FMK is a specific, irreversible Caspase-3 inhibitor.


Caspase-9 抑制剂
Z-LEHD-FMK is a synthetic peptide that irreversibly inhibits caspase-9 and related caspase activity.
A14915 SALE

Q-VD-OPh hydrate

Caspase 抑制剂
Q-VD-OPH is a selective, brain and cell permeable, highly potent and irreversible inhibitor of caspase-3 ( IC50=25nm), caspase-1 (IC50=50nM), caspase-8 (IC50=100nM) and caspase-9 (IC50=430nM).


Caspase 抑制剂
Z-WEHD-FMK is a synthetic peptide that irreversibly inhibits caspase-5 and related caspase activity.

Caspase-3/7 Inhibitor I

Caspase-3/7 抑制剂
Caspase-3/7 Inhibitor I is a potent, cell-permeable, and specific, reversible inhibitor of caspase-3 (Ki = 60 nM) and caspase-7 (Ki = 170 nM).


Fluorogenic caspase substrate
Ac-LEHD-AFC, fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC.

AZ 10417808

Caspase-3 抑制剂
AZ 10417808, selective non-peptide inhibitor of caspase-3 (Ki = 247 nM); displays > 40-fold selectivity over caspases 1, 2, 6, 7 and 8 (Ki > 10 uM).


Caspase-3 抑制剂
Ivachtin is a potent, cell-permeable, reversible, non-competitive inhibitor of Caspase-3 (IC50 = 23 nM).


Caspase-3 activator
PETCM is an activator of caspase-3 and a stimulator of apoptosome formation in HeLa cell cytosols.


Fluorogenic caspase substrate
Ac-LEHD-AFC is a fluorogenic substrate for caspase-4, caspase-5, and caspase-9.


Caspase 抑制剂
Ac-DEVD-CHO is an aldehyde peptide and a CPP32/Apopain Inhibitor.


Caspase-6 抑制剂
Z-VEID-FMK is the specific recognition sequence for caspase-6/Mch2.


Caspase-2 抑制剂
Z-VDVAD-FMK is a cell-permeable, irreversible inhibitor of caspase-2. Caspase inhibitors play an important role in investigating biological processes.


Caspase-3 抑制剂
Z-DQMD-FMK is a synthetic peptide that irreversibly inhibits the activity of Caspase-3.


caspase 8 抑制剂
Z-IETD-FMK is a specific inhibitor of caspase 8.
A10984 SALE

VX-765 (Belnacasan)

Caspase-1/4 抑制剂
VX-765 is a novel Caspase-1 inhibitor,which is an enzyme that controls the generation of two cytokines, IL-1b and IL-18.

产品 1 到 50 共 145个

  1. 1
  2. 2
  3. 3